p63 Immunohistochemistry Is a Useful Adjunct in Distinguishing Sclerosing Cutaneous Tumors

Yang, 1988, p63, a p53 homolog at 3q27-29 encodes multiple products with transactivating, death-inducing, and dominant-negative activities., Mol Cell, 2, 305, 10.1016/S1097-2765(00)80275-0

Yang, 2000, p63 and p73: p53 mimics, menaces and more., Nat Rev Mol Cell Biol, 3, 199, 10.1038/35043127

Yang, 2002, On the shoulders of giants: p63, p73 and the rise of p53., Trends Genet, 18, 90, 10.1016/S0168-9525(02)02595-7

Levrero, 2000, The p53/p63/p73 family of transcription factors: overlapping and distinct functions., J Cell Sci, 113, 1661, 10.1242/jcs.113.10.1661

Pellegrini, 2001, p63 identifies keratinocyte stem cells., Proc Natl Acad Sci U S A, 98, 3156, 10.1073/pnas.061032098

Mills, 1999, p63 is a p53 homologue required for limb and epidermal morphogenesis., Nature, 398, 708, 10.1038/19531

Yang, 1999, p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development., Nature, 398, 714, 10.1038/19539

Parsa, 1999, Association of p63 in proliferative potential in normal and neoplastic human keratinocytes., J Invest Dermatol, 113, 1099, 10.1046/j.1523-1747.1999.00780.x

Di Como, 2002, p63 expression profiles in normal and tumor tissues., Clin Cancer Res, 8, 494

Reis-Filho, 2003, Distribution of p63, cytokeratins 4/6 and cytokeratin 14 and 51 in normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray., Virch Arch, 443, 122, 10.1007/s00428-003-0859-2

Barbareschi, 2002, p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of human breast., Am J Surg Pathol, 25, 1054, 10.1097/00000478-200108000-00010

Reis-Filho, 2002, Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker., Adv Anat Pathol, 9, 280, 10.1097/00125480-200209000-00002

Reis-Filho, 2002, p63 expression in normal skin and usual cutaneous carcinomas., J Cutan Pathol, 29, 517, 10.1034/j.1600-0560.2002.290902.x

Tsujita-Kyutoku, 2003, p63 expression in normal human epidermis and epidermal appendages and their tumors., J Cutan Pathol, 30, 11, 10.1034/j.1600-0560.2003.300102.x

Ivan, 2005, Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to the skin., Mod Pathol, 18, 137, 10.1038/modpathol.3800263

Dotto, 2006, p63 is a useful marker for cutaneous spindle cell squamous cell carcinoma., J Cutan Pathol, 33, 413, 10.1111/j.0303-6987.2006.00477.x

Emanuel, 2005, p63 Immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous cell carcinoma., Mod Pathol, 18, 645, 10.1038/modpathol.3800329

Krahl, 2007, Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma., J Cutan Pathol, 34, 782, 10.1111/j.1600-0560.2006.00710.x

Hoang, 2008, Microcystic adnexal carcinoma: an immunohistochemical reappraisal., Mod Pathol, 21, 178, 10.1038/modpathol.3801000

Abesamis-Cubillan, 2000, Merkel cells and sclerosing epithelial neoplasms., Am J Dermatopathol, 22, 311, 10.1097/00000372-200008000-00003

Katona, 2008, Does the panel of cytokeratin 20 and androgen receptor antibodies differentiate desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma?, J Cutan Pathol, 35, 174, 10.1111/j.1600-0560.2007.00783.x

Goldstein, 1982, Microcystic adnexal carcinoma: a distinct clinicopathologic entity., Cancer, 50, 566, 10.1002/1097-0142(19820801)50:3<566::AID-CNCR2820500330>3.0.CO;2-Q

Chiller, 2000, Microcystic adnexal carcinoma: forty-eight cases, their treatment, and their outcome., Arch Dermatol, 136, 1355, 10.1001/archderm.136.11.1355